Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension (DENERV'AP)
Sponsor: Assistance Publique - Hôpitaux de Paris
Terminated
Refusal of CPP to extend the period of inclusion
Other terminated trials from Assistance Publique - Hôpitaux de Paris
- Hepatocellular Carcinoma · Sep 2025
- Memory Consolidation · Phase NA · Aug 2025
- Knee Injuries · Apr 2025
- Metabolic Syndrome · Phase NA · Dec 2024
- Hemodynamic Instability · Phase NA · Sep 2024
See all terminations from Assistance Publique - Hôpitaux de Paris
Other Pulmonary Arterial Hypertension trials with similar outcome
A NA clinical study on Pulmonary Arterial Hypertension, this trial is terminated or withdrawn. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 9 data snapshots since 2016. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Nov 2024 — Sep 2025 [monthly]
Terminated NA
-
Sep 2024 — Nov 2024 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
▶ Show 4 earlier versions
-
Feb 2019 — Jan 2021 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jun 2018 — Feb 2019 [monthly]
Recruiting NA
-
Sep 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Sep 2017 [monthly]
Recruiting NA
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
- Assistance Publique Hopitaux De Marseille
- Centre Hospitalier Universitaire de Nice
- University Hospital, Grenoble
- University Hospital, Toulouse
For direct contact, visit the study record on ClinicalTrials.gov .